Osteoporosis

• FDA approval · 2007-07-17
  FDA Approved: EVISTA — Supplemental Application (Eli Lilly and Company)

  The FDA approved a supplemental application for EVISTA (raloxifene hydrochloride) from Eli Lilly and Company.

• FDA approval · 2007-05-19
  FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)

  The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.

• FDA approval · 2007-04-26
  FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)

  The FDA approved a supplemental application for FOSAMAX PLUS D (alendronate sodium and cholecalciferol) submitted by Organon LLC. This appro…

• FDA approval · 2007-04-16
  FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for Actonel (risendronate sodium) by Allergan, Inc., under NDA 020835.

• FDA approval · 2006-12-28
  FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Fosamax Plus D (alendronate sodium and cholecalciferol) from Organon LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-07-14
  FDA Approved: PAMIDRONATE DISODIUM — Supplemental Application (Hospira, Inc.)

  FDA approved a supplemental application for pamidronate disodium submitted by Hospira, Inc. The action approves changes associated with the …

• FDA approval · 2006-05-19
  FDA Approved: PAMIDRONATE DISODIUM — Supplemental Application (Hospira, Inc.)

  FDA approved Hospira's supplemental application for pamidronate disodium, confirming the regulatory approval for the product.